Catalyzing Commercialization: Radiochemical Breakthrough Improves PET Imaging

November
,
2014

Ground Fluor Pharmaceuticals, a spinout from the Univ. of Nebraska–Lincoln, has developed new fluorination chemistry that permits a wide range of radiotracers with sufficient activity and purity to meet diverse clinical needs to be made with automated commercial radio-synthesis equipment. Ground Fluor Pharmaceuticals’ innovation, a proprietary method called Swift Iodonium Fluorine Tagging (SWIFT), is based on the work of Stephen DiMagno at the Univ. of Nebraska–Lincoln.

 

Copyright Permissions: 

Would you like to reuse content from CEP Magazine? It’s easy to request permission to reuse content. Simply click here to connect instantly to licensing services, where you can choose from a list of options regarding how you would like to reuse the desired content and complete the transaction.